A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

Biotechnology is the exploitation of biological processes for the development of technologies and products for a specific use. GlobalData’s Strategic Intelligence report on biotech details how recent ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

April M. Kloxin, professor of chemical and biomolecular engineering and materials science and engineering at the University of Delaware, has been named director of the Delaware Biotechnology Institute ...

Moyom Biotechnology recently announced a strategic partnership with WPP Group, one of the world's leading global ...

Explore evolving career pathways in biotechnology, emphasizing innovation, sustainability, and interdisciplinary skills from ...

Venture capitalists point to a surge in M&A and a glint of revival in the IPO arena as signs of better days ahead.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...

PARIS, France – December 18, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on ...